Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Cardiovascular Surgery
  •  Surgical Oncology
  •  Minimally Invasive Surgery
  •  Vascular Surgery
  •  Orthopaedic Surgery
  •  Otolaryngology - Head and Neck Surgery
  •  Colon and Rectal Surgery
  •  Robotic Surgery

Abstract

Citation: Clin Surg. 2021;6(1):3084.Research Article | Open Access

Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy

Boualaoui I*, Bey E, De Villeneuve MH, Dergamoun H, Droupy S and Wagner L

Department of Urology and Andrology, Nimes University Hospital Center, France

*Correspondance to: Boualaoui I 

 PDF  Full Text DOI: 10.25107/2474-1647.3084

Abstract

Introduction: AirSeal? is an insufflation system that enables a stable pneumoperitoneum during laparoscopic surgery, thus providing a permanent renewal of the abdominal gas in a closed system. The aim of this study was to evaluate the medical and economic impact of the AirSeal? system for laparoscopic sacrocolpopexy. Materials and Methods: A preliminary mono-centric retrospective study has been performed during a period of 9 months between May 2019 and February 2020. Post-operative pain was evaluated by a visual analog scale on days 0, 1, and 2. Analgesic and antiemetic use was also collected. The main intraoperative anesthesiologic parameters (morphine and curare doses, peak airways pressure, endtidal CO2 , and temperature) were also studied. The patient?s outing ability was evaluated by the CHUNG score. Results: Thirty-four consecutive patients treated by laparoscopic sacrocolpopexy have been included in the present study. The first 17 were operated using the AirSeal? system and the other half using a standard insufflating system, by the same surgeon. Mean age was 58.9 ? 12.2 years. Postoperative pain was lower in the AirSeal? system group with 40% of morphinic use vs. 52% in the standard system group. The length of stay was also shorter, with 65% of AirSeal? system patients able to leave on an ambulatory basis vs. 35% in the second group, and 95% on first day vs. 76% in the standard insufflation system group. Conclusion: These preliminary results may suggest a positive medical and economic impact of the AirSeal? insufflation system by reducing length of stay, postoperative pain and analgesic use.

Keywords

Sacrocolpopexy; Low impact laparoscopy; laparoscopy; Postoperative pain

Cite the article

Boualaoui I, Bey E, De Villeneuve MH, Dergamoun H, Droupy S, Wagner L. Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy. Clin Surg. 2021; 6: 3084.

Search Our Journal

Journal Indexed In

Articles in PubMed

Sildenafil Transiently Delays Early Alveolar Bone Healing of Tooth Extraction Sockets
 PubMed  PMC  PDF  Full Text
Automated Sagittal Craniosynostosis Classification from CT Images Using Transfer Learning
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Prevalence of Temporomandibular Disorders and Some of Its Risk Factors, According to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)
 Abstract  PDF  Full Text
Total Hysterectomy: Mini-Laparoscopy vs. Single-Port Trans-Umbilical Laparoscopy?
 Abstract  PDF  Full Text
View More...